Orthofix Medical Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $822.3M | $799.5M | $746.6M | $460.7M | $464.5M |
| Gross profit | $566.0M | $545.9M | $486.3M | $337.2M | $349.6M |
| Operating income | -$81.4M | -$84.6M | -$139.1M | -$13.3M | -$8.3M |
| Cost of revenue | $256.3M | $253.6M | $260.4M | $123.5M | $114.9M |
| Cash from operations | $33.3M | $25.8M | -$45.8M | -$11.5M | $18.5M |
| Capital expenditure | $34.6M | $34.9M | $60.3M | $21.4M | $17.8M |
| Free cash flow | -$1.3M | -$9.1M | -$106.0M | -$32.9M | $690,000 |
| Impairments | — | — | — | — | $11.8M |
| Total assets | $850.6M | $893.3M | $925.3M | $458.6M | $476.6M |
| Total liabilities | $400.6M | $390.2M | $326.6M | $121.8M | $139.7M |
Shares outstanding 40.4M · Free float 53.6%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.